Identifying & Addressing Unmet Needs of Injury Survivors at a Safety Net Hospital in San Francisco
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 25
- 试验地点
- 2
- 主要终点
- Early Implementation Outcomes - Acceptability, Appropriateness, Feasibility
研究概览
简要总结
The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is:
• Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors?
Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient ≥ 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital
- •Admitted to the hospital ≥ 24 hours
- •Discharged from the hospital alive
- •San Francisco resident or unhoused in San Francisco
- •Capacity for informed consent
排除标准
- •Patient < 18 years old
- •Deceased during index hospitalization
- •Unable to provide informed consent
研究组 & 干预措施
Injury Thrivorship Pathway
Enrollment in the human-centered injury thrivorship pathway.
干预措施: Human-Centered Injury Thrivorship Pathway (Other)
结局指标
主要结局
Early Implementation Outcomes - Acceptability, Appropriateness, Feasibility
时间窗: 8-12 weeks post-pathway enrollment
Early implementation outcomes will be assessed via purposive sampling of pathway participants, their caregivers, and trauma care stakeholders for in-depth semi-structured interviews. "Acceptability is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Appropriateness is the perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Feasibility is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting."
次要结局
- Participant pathway resource utilization - type(8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year)
- Participant pathway resource utilization - frequency(8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year)
- Participant pathway resource utilization - % utilized(8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year)
- Participant pathway resource utilization - duration(8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year)